Clinical Trials Directory

Trials / Completed

CompletedNCT06424938

Postoperative Analgesia in Major Gynecological Cancer Surgeries

The Effect of Epidural Analgesia and Erector Spinae Plane Block on Intraoperative and Early Postoperative Outcomes in Open Gynecological Oncological Surgeries: a Prospective Randomized Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
71 (actual)
Sponsor
Duygu Akyol · Other Government
Sex
Female
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to compare the effectiveness of epidural block or erector spinae plane block applied for postoperative analgesia in gynecological cancer surgeries. The main question(s) it aims to answer are: \[Is erector spinae plane block as effective as epidural block in postoperative analgesia?\] The study was designed as a prospective randomized study. Researchers evaluated the effects of epidural block or erector spinae plane block applied for postoperative analgesia on pain scores, postoperative opioid use, and mobilization in patients undergoing gynecological cancer surgery.

Detailed description

Our study was designed as a prospective randomized study. The investigators evaluated the analgesia methods used in patients undergoing surgery for gynecologic cancer between May 2024 and December 2024. The investigators evaluated the effect of epidural block or erector spina plan block on postoperative analgesia, opioid use and mobilization. Group 1: Epidural block group Group 2: Group with erector spina plan block

Conditions

Interventions

TypeNameDescription
PROCEDUREPatients who underwent epidural blockThe researchers administered an epidural block to prevent post-operative pain to the epidural block group undergoing midline incision surgery for major gynecologic cancer.
PROCEDUREPatients who underwent erector spina plane blockResearchers applied a erector spina plane block to prevent postoperative pain to the erector spina plane block group undergoing midline incision surgery for major gynecological cancer.

Timeline

Start date
2024-07-01
Primary completion
2025-01-01
Completion
2025-01-31
First posted
2024-05-22
Last updated
2025-09-22

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06424938. Inclusion in this directory is not an endorsement.